Evidence map›Paper›PMID 29242278›Full record

ReviewFASEB journal : official publication of the Federation of American Societies for Experimental Biology2018

AMPK in skeletal muscle function and metabolism.

Rasmus Kjøbsted, Janne R Hingst, Joachim Fentz, Marc Foretz, Maria-Nieves Sanz, Christian Pehmøller, Michael Shum, André Marette, Remi Mounier, Jonas T Treebak and 3 more

Open access · hybridAbstract readReview
In one paragraph

Review in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 287 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
287citing papers in PubMed, 3 pooled it
14.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

287 citing papers in PubMed, 3 syntheses or guidelines pooled it, 464 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Effects ofNutrients · 2026
    Trial
  5. Anabolic Effects of Salbutamol Are Lost Upon Immobilization.Journal of cachexia, sarcopenia and muscle · 2025
    Trial
  6. Trial
  7. Trial
  8. Trial
  9. Marine Oil fromNutrients · 2022
    Trial
  10. Review
  11. Modulation of Hepatic Cholesterol-Related Pathways byMolecules (Basel, Switzerland) · 2026
    Article
  12. Exercise as a modulator of purinergic signaling and inflammation in cancer-associated sarcopenia: a narrative review.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

227 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 5 countries.

Rasmus KjøbstedSection of Molecular Physiology, Department of Nutrition, Exercise, and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.
Janne R HingstSection of Molecular Physiology, Department of Nutrition, Exercise, and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.
Joachim FentzSection of Molecular Physiology, Department of Nutrition, Exercise, and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.
Marc ForetzINSERM, Unité 1016, Institut Cochin, Paris, France.
Maria-Nieves SanzDepartment of Cardiovascular Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland, and.
Christian PehmøllerInternal Medicine Research Unit, Pfizer Global Research and Development, Cambridge, Massachusetts, USA.
Michael ShumAxe Cardiologie, Quebec Heart and Lung Research Institute, Laval University, Québec, Canada.
André MaretteAxe Cardiologie, Quebec Heart and Lung Research Institute, Laval University, Québec, Canada.
Remi MounierInstitute NeuroMyoGène, Université Claude Bernard Lyon 1, INSERM Unité 1217, CNRS UMR, Villeurbanne, France.
Jonas T TreebakSection of Integrative Physiology, Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Jørgen F P WojtaszewskiSection of Molecular Physiology, Department of Nutrition, Exercise, and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.
Benoit ViolletINSERM, Unité 1016, Institut Cochin, Paris, France.
Louise LantierDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, USA.
University of Copenhagen · DKDélégation Paris 5 · FRLung Institute · USPfizer (United States) · USUniversité Claude Bernard Lyon 1 · FRUniversity of Bern · CHVanderbilt University · US

Funding

Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
INTEGRATED CONTROL OF MUSCLE GLUCOSE UPTAKE IN VIVOR01DK054902 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 1999 to 2020
$5.9M
Integrated Control of Muscle Glucose Uptake in VivoR56DK054902 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2009 to 2009
$388k
CIHR FDN-143247NIDDK NIH HHS R01 DK054902NIDDK NIH HHS R56 DK054902NIDDK NIH HHS U24 DK059637
6 · The paper itself

Abstract

Skeletal muscle possesses a remarkable ability to adapt to various physiologic conditions. AMPK is a sensor of intracellular energy status that maintains energy stores by fine-tuning anabolic and catabolic pathways. AMPK's role as an energy sensor is particularly critical in tissues displaying highly changeable energy turnover. Due to the drastic changes in energy demand that occur between the resting and exercising state, skeletal muscle is one such tissue. Here, we review the complex regulation of AMPK in skeletal muscle and its consequences on metabolism ( e.g., substrate uptake, oxidation, and storage as well as mitochondrial function of skeletal muscle fibers). We focus on the role of AMPK in skeletal muscle during exercise and in exercise recovery. We also address adaptations to exercise training, including skeletal muscle plasticity, highlighting novel concepts and future perspectives that need to be investigated. Furthermore, we discuss the possible role of AMPK as a therapeutic target as well as different AMPK activators and their potential for future drug development.-Kjøbsted, R., Hingst, J. R., Fentz, J., Foretz, M., Sanz, M.-N., Pehmøller, C., Shum, M., Marette, A., Mounier, R., Treebak, J. T., Wojtaszewski, J. F. P., Viollet, B., Lantier, L. AMPK in skeletal muscle function and metabolism.

Indexed as

Adaptation, PhysiologicalAMP-Activated Protein Kinase KinasesAnimalsEnergy MetabolismExerciseHumansMuscle, SkeletalProtein KinasesAMP-Activated Protein Kinase KinasesProtein Kinasesdiabetesexerciseglucose uptakemitochondriaplasticity

Identifiers

PMID29242278
PMCPMC5945561
OpenAlexW2771593201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.